Cargando…
Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
A simple, sensitive, specific, spectrophotometric method was developed for the detection of Olmesartan medoxomil (OLM) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of the drug were established. OLM was subjected to stress degradation under different conditions rec...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658033/ https://www.ncbi.nlm.nih.gov/pubmed/23781428 http://dx.doi.org/10.4103/2229-4708.81092 |
_version_ | 1782270212175822848 |
---|---|
author | Patel, Jaydeep Kevin, Garala Patel, Anjali Raval, Mihir Sheth, Navin |
author_facet | Patel, Jaydeep Kevin, Garala Patel, Anjali Raval, Mihir Sheth, Navin |
author_sort | Patel, Jaydeep |
collection | PubMed |
description | A simple, sensitive, specific, spectrophotometric method was developed for the detection of Olmesartan medoxomil (OLM) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of the drug were established. OLM was subjected to stress degradation under different conditions recommended by the International Conference on Harmonization (ICH). The samples so generated were used for degradation studies using the developed method. The λ(max) of the OLM was found to be 257 nm. The method exhibited high sensitivity, with linearity, in the 2 to 20 μg/ml range. The lower limit of detection and the limit of quantification were found to be 1.012 μg/ml and 3.036 μg/ml, respectively. All the calibration curves demonstrated a linear relationship between the absorbance and concentration, with the correlation coefficient higher than 0.99. The regression equation of the curve was Y = 0.0579x + 0.0006. The precision of the method was found to be 40.043 ± 0.067 against the label claim of 40 mg. The percentage recovery was found to be 101.32 ± 0.452. The sample solution was stable for up to two hours. Hence, it could be concluded that the proposed method would be suitable for the analysis of OLM in bulk and pharmaceutical formulations. |
format | Online Article Text |
id | pubmed-3658033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36580332013-06-18 Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies Patel, Jaydeep Kevin, Garala Patel, Anjali Raval, Mihir Sheth, Navin Pharm Methods Original Article A simple, sensitive, specific, spectrophotometric method was developed for the detection of Olmesartan medoxomil (OLM) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of the drug were established. OLM was subjected to stress degradation under different conditions recommended by the International Conference on Harmonization (ICH). The samples so generated were used for degradation studies using the developed method. The λ(max) of the OLM was found to be 257 nm. The method exhibited high sensitivity, with linearity, in the 2 to 20 μg/ml range. The lower limit of detection and the limit of quantification were found to be 1.012 μg/ml and 3.036 μg/ml, respectively. All the calibration curves demonstrated a linear relationship between the absorbance and concentration, with the correlation coefficient higher than 0.99. The regression equation of the curve was Y = 0.0579x + 0.0006. The precision of the method was found to be 40.043 ± 0.067 against the label claim of 40 mg. The percentage recovery was found to be 101.32 ± 0.452. The sample solution was stable for up to two hours. Hence, it could be concluded that the proposed method would be suitable for the analysis of OLM in bulk and pharmaceutical formulations. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3658033/ /pubmed/23781428 http://dx.doi.org/10.4103/2229-4708.81092 Text en Copyright: © Pharmaceutical Methods http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Patel, Jaydeep Kevin, Garala Patel, Anjali Raval, Mihir Sheth, Navin Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
title | Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
title_full | Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
title_fullStr | Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
title_full_unstemmed | Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
title_short | Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
title_sort | development of the uv spectrophotometric method of olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658033/ https://www.ncbi.nlm.nih.gov/pubmed/23781428 http://dx.doi.org/10.4103/2229-4708.81092 |
work_keys_str_mv | AT pateljaydeep developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies AT kevingarala developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies AT patelanjali developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies AT ravalmihir developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies AT shethnavin developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies |